1. Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: Efficacy, safety and patient selection;Abbruzzese;Functional Neurology,2012
2. Pathogenesis-targeted, disease-modifying therapies in Parkinson disease;AlDakheel;Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics,2014
3. Continuous dopaminergic delivery in Parkinson's disease;Antonini;Journal of Neurology,2010
4. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease;Bibbiani;Experimental Neurology,2003
5. Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain;Brooks;Synapse,2008